Related Experiment Video
Updated: Aug 8, 2026
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
Published on: December 3, 2019
Prophylaxis against Mycobacterium avium-intracellulare complex infections in human immunodeficiency virus-infected
Abstract:
Infection due to the Mycobacterium avium complex (MAC) accounts for the most frequent AIDS-related opportunistic infections, but MAC infection is usually not the first AIDS-defining event that a patient infected with HIV experiences. The incidence increases linearly over time, at a rate of 20 to 25% per year, after a patient's first AIDS-defining event, and the incidence increases exponentially as the CD4+ cell count approaches zero. There is evidence that MAC may eventually infect most if not all HIV-infected patients who do not die from another HIV-related event. Since MAC infection contributes substantially to the morbidity and mortality of AIDS patients, prophylaxis appears to be mandatory. Rifabutin was the first drug which was shown to be effective in preventing MAC infection, and, recently, prophylaxis with clarithromycin was also found to prevent the disease. The optimal approach to prophylaxis still needs to be defined. Since a large majority of MAC infections occur in patients with CD4+ cell counts below 50/microliter, recommendations regarding the prophylaxis of patients with a history of an AIDS-defining opportunistic event and a CD4+ cell count between 50 and 200/microliter can be individualized, depending for example on how well the patient seems to be responding to antiretroviral treatment. Prophylaxis against MAC should be provided for any HIV-infected patient with a CD4+ cell count less than 50/microliter.
Insights
Prophylaxis against Mycobacterium avium complex (MAC) infection is crucial for individuals with HIV/AIDS. Current guidelines recommend MAC infection prophylaxis for all HIV-infected patients with a CD4+ cell count below 50/microliter.
Area of Science:
- Infectious Diseases
- Immunology
- Public Health
Background:
- Mycobacterium avium complex (MAC) infections are common opportunistic infections in AIDS patients.
- MAC infection incidence rises with time post-AIDS diagnosis and decreases in CD4+ cell counts.
- MAC infection significantly contributes to AIDS patient morbidity and mortality.
Purpose of the Study:
- To review the current understanding of Mycobacterium avium complex (MAC) infections in HIV-infected patients.
- To discuss the role and recommendations for MAC infection prophylaxis.
- To highlight the importance of CD4+ cell counts in guiding prophylaxis decisions.
Main Methods:
- Literature review of studies on MAC infection in HIV/AIDS.
- Analysis of incidence rates based on time and CD4+ cell counts.
- Evaluation of current prophylactic strategies and drug efficacy.
Main Results:
- MAC infection is a frequent AIDS-related opportunistic infection, typically not the initial AIDS-defining event.
- Incidence of MAC infection increases annually post-AIDS diagnosis and exponentially as CD4+ counts decline.
- Rifabutin and clarithromycin have demonstrated efficacy in preventing MAC infection.
Conclusions:
- Prophylaxis against MAC infection is considered mandatory for HIV-infected patients.
- Prophylaxis is strongly recommended for patients with CD4+ cell counts less than 50/microliter.
- Individualized prophylaxis strategies may be considered for patients with CD4+ counts between 50-200/microliter, depending on antiretroviral treatment response.
Related Concept Videos
01:25Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:27Cryptococcal Meningitis